Cleerly LABS vs DeepTek CXR Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by DeepTek

AI Verdict

Cleerly LABS specializes in comprehensive, AI-powered analysis of coronary CT angiography for detailed assessment of coronary artery disease, including plaque characterization and stenosis. DeepTek CXR Analyzer, conversely, focuses on AI-assisted detection of a broad range of lung, pleural, and cardiac pathologies on chest X-rays to enhance radiologist workflow. While both are FDA-cleared AI tools for medical imaging with a cardiology component, their distinct imaging modalities and specific analytical depths target different clinical needs.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify atherosclerosis and stenosis. This tool is ideal for cardiologists and radiologists focused on personalized heart disease management, including detailed risk assessment and tracking disease progression over time.

View Cleerly LABS →

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if you require an efficient, FDA-cleared AI-powered CADe solution to assist with high-volume chest X-ray interpretations. This tool is best suited for radiology departments aiming to significantly improve workflow efficiency and diagnostic accuracy by automatically detecting and highlighting suspicious regions across various lung, pleural, and cardiac pathologies.

View DeepTek CXR Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS DeepTek CXR Analyzer
Pricing Varies Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.
Deployment Cloud, On-premise On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer's focus on seamless, backend integration, intelligent triaging, and direct DICOM output for easy interpretation suggests a highly streamlined and less disruptive workflow for radiologists. This approach aims to reduce workload and boost productivity by fitting directly into existing processes, making it highly usable in high-volume environments.

Clinical Value

Cleerly LABS

While both are FDA-cleared and offer significant clinical value, Cleerly LABS provides a more transformative clinical impact by moving beyond simple detection to comprehensive plaque characterization, personalized risk assessment, and tracking disease progression for a critical condition like CAD. This depth of analysis and its proven ability to reduce unnecessary invasive procedures offer a higher level of personalized and preventative care.

Pricing & Value

Cleerly LABS

Cleerly LABS, despite its initial high retail price, now has established and expanding insurance coverage from major payors, including UnitedHealthcare, Cigna, Aetna, and Medicare, significantly improving its accessibility and reducing patient out-of-pocket expenses. This widespread coverage provides a more concrete and quantifiable value proposition for patients and providers compared to DeepTek's less transparent 'pay-per-use' model, even with its claimed productivity gains.

Enterprise Readiness

DeepTek CXR Analyzer

While both are FDA-cleared, HIPAA compliant, and offer BAA, DeepTek CXR Analyzer provides greater deployment flexibility with both cloud and on-premise options, catering to a wider range of enterprise IT infrastructures and security preferences. Furthermore, its extensive list of international regulatory approvals and certifications (ISO 13485, ISO 27001, GDPR, SOC 2) demonstrates a more robust and globally-minded approach to enterprise readiness.

Innovation

Cleerly LABS

Cleerly LABS demonstrates a higher degree of innovation by fundamentally shifting the paradigm of cardiovascular disease management from stenosis-focused detection to comprehensive plaque characterization, personalized risk assessment, and disease progression tracking. This proactive and preventative approach, supported by advanced 3D visualization and AI, represents a more transformative application of AI in clinical practice.

Support & Docs

Cleerly LABS

Cleerly LABS provides clear and explicit information regarding its customer support availability, including specific hours of operation (Monday-Friday, 10 am ET to 6 pm ET) and a dedicated online form for existing users to request technical assistance. While DeepTek hints at a robust support infrastructure through its '140+ Experts delivering 24x7 services' for its reporting service, it lacks specific details about support for its CXR Analyzer software, making Cleerly's offering more transparent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS DeepTek CXR Analyzer
Tool Name Cleerly LABS DeepTek CXR Analyzer
Company Cleerly DeepTek Medical Imaging Pvt
Primary Imaging Modality Coronary CT Angiography (CCTA) Chest X-ray
Key AI Capabilities AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time AI-Powered Computer-Assisted Detection (CADe) for Chest X-rays, detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware, automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs), intelligent segregation of scans into 'AI Finding-Negative' and 'AI Finding-Positive'
Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and DeepTek CXR Analyzer.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered software specifically designed for the comprehensive analysis of coronary CT angiography (CCTA) images. In contrast, DeepTek CXR Analyzer is an AI-powered computer-assisted detection (CADe) solution focused on analyzing chest X-ray (CXR) images.
Cleerly LABS detects, quantifies, and characterizes atherosclerosis and stenosis, and can also detect ischemia when used with its ISCHEMIA module. DeepTek CXR Analyzer automatically detects and highlights suspicious regions across 28 findings, covering lung, pleural, cardiac pathologies, and hardware.
Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at a discounted rate of $750, though the CCTA scan cost is separate and total out-of-pocket expenses can range from $1000-$1500. DeepTek CXR Analyzer operates on a pay-per-use model, with specific pricing details requiring direct contact with sales, and is available as a technology offering or an AI-assisted reporting service.
Cleerly LABS facilitates integration with PACS, RIS, and EHR systems through its Cleerly Proxy. DeepTek CXR Analyzer offers seamless DICOM-based PACS integration, which is compatible with both on-premise and cloud deployments.
Cleerly LABS aids in personalized heart disease risk assessment, management, and tracking disease progression over time. DeepTek CXR Analyzer is designed to reduce radiologist workload by 30-50% and boost productivity by 2x-3x by intelligently segregating scans and highlighting suspicious regions.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.